Skip to main content

Day: June 28, 2022

Dassault Aviation accelerates its digital transformation with Capgemini

Press contact: Florence LievreTel.: +33 1 47 54 50 71E-mail: florence.lievre@capgemini.com Dassault Aviation accelerates its digital transformation with Capgemini Paris, June 28, 2022 – Dassault Aviation and Capgemini have announced the successful deployment and commissioning of a new software foundation leveraging SAP solutions at all of the aircraft manufacturer’s French industrial sites. This project is part of the “Piloting our Future” program, Dassault Aviation’s transformation plan launched five years ago, aimed at modernizing infrastructures and processes and improving the Group’s competitiveness. It represents the achievement of the first major phase in the transformation of the technology used for managing operations. Dassault Aviation called on Capgemini’s expertise in managing major transformation...

Continue reading

Update re share issue: Major shareholders confirm subscription

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Oslo, 28 June 2022 Interoil Exploration and Production ASA (the “Company”) is pleased to inform that Integra Oil and Gas SA (“Integra”) and International Capital Markets Group (“ICMG”), two leading and long-term shareholders in the Company, have each confirmed subscription of shares worth USD 300,000 in the ongoing fund raise. The combined commitment of the two represents approximately 20 per cent of the maximum number of shares offered in the ongoing share issue. For both Integra and ICMG this represents a significant additional investment in Interoil, signaling their strong belief in the Company...

Continue reading

6,214 Orion Corporation A shares converted into B shares

ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE28 JUNE 2022 at 9.30 EEST          6,214 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 6,214 A shares have been converted into 6,214 B shares. The conversion has been entered into the Trade Register on 28 June 2022. The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 34,476,321 A shares and 106,657,957 B shares. The number of votes of the company’s shares is after the conversion 796,184,377. Orion CorporationJari Karlson CFO     Olli Huotari SVP, Corporate Functions                                                  Contact person:Tuukka Hirvonen, Investor Relations, tel. +358...

Continue reading

Sampo plc’s share buybacks 27/06/2022

SAMPO PLC                 STOCK EXCHANGE RELEASE         28/06/2022 at 08:30 am Sampo plc’s share buybacks 27/06/2022 On 27/06/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  13,750 41.26 AQEU  37,253 41.36 CEUX  8,702 41.09 TQEX  80,573 41.27 XHELTOTAL 140,278 41.28  *rounded to two decimals                 On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based...

Continue reading

Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD

Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD Paris, June 28, 2022. The European Commission (EC) has approved Xenpozyme® (olipudase alfa) as the first and only enzyme replacement therapy for the treatment of non-Central Nervous System (CNS) manifestations of Acid Sphingomyelinase Deficiency (ASMD) in pediatric and adult patients with ASMD type A/B or ASMD type B. The approval is based on positive data from the ASCEND and ASCEND-Peds clinical trials, in which Xenpozyme showed substantial and clinically relevant improvement in lung function (as measured by diffusing capacity of the lung for carbon monoxide, or DLco) and reduction of spleen and liver volumes, with a well-tolerated safety profile. Given the urgent unmet medical needs of the ASMD community, the European Medicines Agency (EMA)...

Continue reading

Bureau Veritas acquires Advanced Testing Laboratory, a US leader in scientific sourcing

PRESS RELEASE Neuilly-sur-Seine, France – June 28, 2022 Bureau Veritas acquires Advanced Testing Laboratory, a US leader in scientific sourcing Expanding BV’s footprint in Consumer Products and Consumer Healthcare markets Bureau Veritas, a world leader in testing, inspection and certification, announced the acquisition of Advanced Testing Laboratory (ATL), a leader in scientific sourcing services for the North American Consumer Healthcare Products, Cosmetics & Personal Care and Medical Device markets.    Headquartered in Cincinnati, Ohio, ATL’s services span the entire product life cycle, from research and development to substance and product qualification to manufacturing. Services include Analytical Chemistry, Engineering, Life Science, Product Performance, Product Safety & Regulatory, Quality Assurance and Regulatory Compliance. The...

Continue reading

Solutions 30 enters into exclusive negotiations for the acquisition of EnergyGo

Solutions 30 today announced that it has entered into exclusive negotiations for the acquisition of EnergyGo, a specialist in energy renovation. With this transaction, the group confirms that it is resuming its external growth strategy and is accelerating the development of its activities in the field of energy transition, a market that is estimated to represent nearly €20 billion per year in France and which is a significant driver of programmes to reduce energy consumption throughout Europe. Founded in 2010, EnergyGo offers turnkey energy renovation solutions to households eligible for subsidies. EnergyGo operates in a dynamic market, supported by government stimulus plans to accelerate energy transition and addresses a triple challenge: (i) fight against climate change, (ii) support cost-of-living through reduced energy bills and (iii)...

Continue reading

Van Lanschot Kempen successfully issued inaugural €500 million Soft Bullet Covered Bond

Amsterdam/’s-Hertogenbosch, the Netherlands, 28 June 2022 27 June 2022, Van Lanschot Kempen successfully issued its inaugural €500 million long 5 year Soft Bullet Covered Bond with a 2.500% fixed coupon. The deal had a final order book of over €700 million and was placed with a broad range of European institutional investors. The transaction further strengthens and diversifies Van Lanschot Kempen’s funding profile. The bonds are rated AAA by Standard & Poor’s. Van Lanschot Kempen’s Soft Bullet Covered Bond Programme is Dutch law-based and backed by a pool of Dutch residential mortgage loans. It is registered with De Nederlandsche Bank and is both UCITS-compliant and CRD-compliant. Van Lanschot Kempen mandated ABN AMRO, Credit Suisse, LBBW, Natixis and Rabobank as Joint Lead Managers for this transaction. Media Relations: +31 20 354...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.